Lecanemab (Leqembi™) A newly approved drug to delay progression of Alzheimer’s in the early stage group costs about $28,000 out of pocket annually with an additional cost for all the required MRIs of about $5,000 each. Medicare will not pay for this because it was on accelerated approval so perhaps in a year it will be covered. Meanwhile, those in the early stage may progress to middle stage by that time and not be eligible to receive the drug. It seems like only the rich will get it. I am interested in your thoughts.
6 Answers
Helpful Newest
First Oldest
First
ADVERTISEMENT
The politicians need to get OUT of the pockets of Big Pharma once and for all, for crying out loud.
Then $3 worth of pills won't cost us $28,000 + $5K for MRIs that cost another $5, but Medicare or insurance is billed $2K per.
But the corrupt politicians don't care about US, they never have. All of their needs are met with no problem whatsoever b/c money comes to them by the millions, at the taxpayers expense. How that ever happened, that a congressperson like AOC can be worth $29 million in her short 'service' as a politician is beyond RIDICULOUS. While an Alzheimer's patient is turned down for a new medication which isn't 'approved' by Medicare is a very sad statement of what our country has devolved into.
It's irrelevant whether I'd choose to take this drug or not; that it's NOT available to me as a Medicare recipient IS the relevant issue.
Find a neuropsychologist to start the evaluation process (they are in short supply). Medicare WILL pay for a comprehensive neurocognitive evaluation (there was no special process to get my mom or my DH approved for this extensive testing).
There is a suggestion perhaps patients with AD will be funded by Medicare in the same way that End Stage Renal Disease is.